14-23389008-G-T
Variant summary
Our verdict is Uncertain significance. The variant received 3 ACMG points: 8P and 5B. PVS1BP6BS2
The NM_002471.4(MYH6):c.4026C>A(p.Cys1342*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000484 in 1,613,094 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. C1342C) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_002471.4 stop_gained
Scores
Clinical Significance
Conservation
Publications
- hypertrophic cardiomyopathy 14Inheritance: AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Laboratory for Molecular Medicine
- Keppen-Lubinsky syndromeInheritance: AD Classification: MODERATE Submitted by: Illumina
- familial isolated dilated cardiomyopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- atrial septal defect 3Inheritance: AD Classification: LIMITED Submitted by: G2P
- dilated cardiomyopathyInheritance: AD Classification: LIMITED Submitted by: ClinGen
- hypertrophic cardiomyopathyInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 3 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_002471.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| MYH6 | NM_002471.4 | MANE Select | c.4026C>A | p.Cys1342* | stop_gained | Exon 29 of 39 | NP_002462.2 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| MYH6 | ENST00000405093.9 | TSL:5 MANE Select | c.4026C>A | p.Cys1342* | stop_gained | Exon 29 of 39 | ENSP00000386041.3 |
Frequencies
GnomAD3 genomes AF: 0.0000592 AC: 9AN: 152022Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000879 AC: 22AN: 250412 AF XY: 0.0000738 show subpopulations
GnomAD4 exome AF: 0.0000472 AC: 69AN: 1461072Hom.: 0 Cov.: 33 AF XY: 0.0000537 AC XY: 39AN XY: 726794 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000592 AC: 9AN: 152022Hom.: 0 Cov.: 32 AF XY: 0.0000808 AC XY: 6AN XY: 74226 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:2
Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene or region of a gene for which loss of function is not a well-established mechanism of disease; Has not been previously published in association with a cardiac phenotype to our knowledge; This variant is associated with the following publications: (PMID: 23861362)
Cardiovascular phenotype Uncertain:1
The p.C1342* variant (also known as c.4026C>A), located in coding exon 27 of the MYH6 gene, results from a C to A substitution at nucleotide position 4026. This changes the amino acid from a cysteine to a stop codon within coding exon 27. This alteration is expected to result in premature protein truncation or nonsense-mediated mRNA decay. However, loss of function of MYH6 has not been clearly established as a mechanism of disease. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
Hypertrophic cardiomyopathy 14 Benign:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at